Long-term care pharmacy to pay $3 million over dispensing, reimbursement violations - McKnight's Long-Term Care News
Long-term care pharmacy to pay $3 million for dispensing and reimbursement violations.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All long-term care pharmacies and potentially affected pharmacies involved in dispensing and reimbursement processes. should confirm how it applies to their specific situation before acting. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmacy & Controlled Substances move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
A significant financial penalty has been imposed for violations related to dispensing and reimbursement practices.
Who it affects
All long-term care pharmacies and potentially affected pharmacies involved in dispensing and reimbursement processes.
What you must do
Review dispensing and reimbursement practices to ensure compliance with regulations to avoid similar penalties.
Deadline
No fixed deadline was published, but changes like this are often enforced quickly — act promptly.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
- PA HB 2749: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.
- Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
- Catina Allen, N.P.; Decision and Order